[1]
Mostafid, H. 2021. No ‘one size fits all’ approach in the management of high-risk non-muscle invasive bladder cancer. Scandinavian Journal of Urology. 55, 1 (Jan. 2021), 53–53. DOI:https://doi.org/10.1080/21681805.2020.1866661.